Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
gap junction protein beta 2 | 0.441 | 0.846 | 6.6E-16 |
|
disease | 0.700 | None | 0.973 | 0 | 4 | 1994 | 2020 | ||||||||
|
solute carrier family 26 member 4 | 0.507 | 0.885 | 9.0E-22 |
|
disease | 0.700 | strong | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
myosin heavy chain 9 | 0.505 | 0.808 | 1.00 |
|
disease | 0.490 | strong | 0.900 | 0 | 0 | 2000 | 2019 | ||||||||
|
gap junction protein beta 3 | 0.621 | 0.462 | 2.2E-03 |
|
disease | 0.450 | None | 1.000 | 0 | 0 | 2001 | 2018 | ||||||||
|
transmembrane channel like 1 | 0.769 | 0.346 | 9.2E-19 |
|
disease | 0.440 | strong | 1.000 | 0 | 0 | 2008 | 2018 | ||||||||
|
LIM homeobox 3 | 0.644 | 0.462 | 1.1E-02 |
|
disease | 0.430 | strong | 1.000 | 0 | 0 | 2008 | 2017 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 0.420 | None | 1.000 | 0 | 0 | 2004 | 2008 | ||||||||
|
collagen type XI alpha 2 chain | 0.435 | 0.846 | 0.70 |
|
disease | 0.410 | None | 1.000 | 0 | 1 | 2006 | 2007 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
disease | 0.410 | strong | 1.000 | 0 | 0 | 1996 | 2008 | ||||||||
|
LDL receptor related protein 2 | 0.491 | 0.846 | 1.00 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 2007 | 2014 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2006 | 2006 | ||||||||
|
collagen type IX alpha 1 chain | 0.566 | 0.731 | 3.1E-19 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2006 | 2006 | ||||||||
|
Dmx like 2 | 0.695 | 0.538 | 1.00 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2012 | 2019 | ||||||||
|
ring finger protein 13 | 0.722 | 0.346 | 4.0E-04 |
|
disease | 0.400 | moderate | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
iroquois homeobox 5 | 0.623 | 0.846 | 0.97 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2012 | 2012 | ||||||||
|
endothelin receptor type B | 0.470 | 0.846 | 9.2E-03 |
|
disease | 0.300 | None | 1.000 | 0 | 2 | 2011 | 2011 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 10 | 0.599 | 0.654 | 0.15 |
|
disease | 0.300 | None | 1.000 | 0 | 0 | 2014 | 2014 | ||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
disease | 0.200 | None | 0.933 | 0 | 1 | 2001 | 2018 | ||||||||
|
barttin CLCNK type accessory subunit beta | 0.603 | 0.692 | 1.1E-10 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 2001 | 2018 | ||||||||
|
ATPase H+ transporting V1 subunit B1 | 0.695 | 0.346 | 2.4E-09 |
|
disease | 0.200 | None | 0.952 | 0 | 0 | 1999 | 2020 | ||||||||
|
gap junction protein beta 6 | 0.528 | 0.808 | 1.7E-07 |
|
disease | 0.200 | None | 0.944 | 0 | 0 | 2001 | 2019 | ||||||||
|
cochlin | 0.659 | 0.385 | 1.2E-07 |
|
disease | 0.200 | None | 0.923 | 0 | 0 | 2001 | 2019 | ||||||||
|
EYA transcriptional coactivator and phosphatase 4 | 0.604 | 0.615 | 4.9E-02 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 2000 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.170 | None | 1.000 | 0 | 0 | 2000 | 2019 |